Doseloop Beta

Mexiletine

medication Under review

A Class IB antiarrhythmic medication used to treat ventricular arrhythmias, chronic pain, and muscle stiffness.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

Mexiletine has been extensively studied in clinical populations with cardiac arrhythmias and genetic conditions. Research demonstrates significant efficacy in reducing ventricular arrhythmias, with studies showing reductions in premature ventricular complexes and ventricular tachycardia in a substantial proportion of patients. However, the available evidence focuses primarily on patients with existing cardiac conditions or genetic disorders rather than healthy populations. Clinical trials have established dosing protocols and safety profiles in these patient populations.

Reported Benefits

No side effects tracked yet

No side effects have been reported by studies or users for this habit yet.

Related health conditions

Research showing how this habit affects specific health conditions. Always consult healthcare professionals.

May Help With

Research (3 studies)

Cohort study

Mexiletine: Long-term Efficacy and Side Effects in Patients With Ventricular Arrhythmias

JAMA Internal Medicine • n=100

Not specified in source

Cohort study

Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients.

Circulation • 2024 • n=96

Not specified in source

Systematic Review

Effectiveness and safety of mexiletine in patients at risk for (recurrent) ventricular arrhythmias

PMC/NCBI • 2022 • n=8970

Not specified in source

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 3
Researched benefits 2
Side effects noted 0